These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 16306937)

  • 1. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
    Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
    Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
    Oganesyan G; Saha SK; Guo B; He JQ; Shahangian A; Zarnegar B; Perry A; Cheng G
    Nature; 2006 Jan; 439(7073):208-11. PubMed ID: 16306936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
    Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
    J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
    Takaoka A; Yanai H; Kondo S; Duncan G; Negishi H; Mizutani T; Kano S; Honda K; Ohba Y; Mak TW; Taniguchi T
    Nature; 2005 Mar; 434(7030):243-9. PubMed ID: 15665823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.
    Sasai M; Tatematsu M; Oshiumi H; Funami K; Matsumoto M; Hatakeyama S; Seya T
    Mol Immunol; 2010 Mar; 47(6):1283-91. PubMed ID: 20047764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
    Akira S; Hoshino K
    J Infect Dis; 2003 Jun; 187 Suppl 2():S356-63. PubMed ID: 12792852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.
    Hoebe K; Du X; Georgel P; Janssen E; Tabeta K; Kim SO; Goode J; Lin P; Mann N; Mudd S; Crozat K; Sovath S; Han J; Beutler B
    Nature; 2003 Aug; 424(6950):743-8. PubMed ID: 12872135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
    Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
    Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIR-containing adaptors in Toll-like receptor signalling.
    Jenkins KA; Mansell A
    Cytokine; 2010 Mar; 49(3):237-44. PubMed ID: 19264502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.
    Liu-Bryan R; Scott P; Sydlaske A; Rose DM; Terkeltaub R
    Arthritis Rheum; 2005 Sep; 52(9):2936-46. PubMed ID: 16142712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
    Youn HS; Saitoh SI; Miyake K; Hwang DH
    Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules.
    Yamamoto M; Yaginuma K; Tsutsui H; Sagara J; Guan X; Seki E; Yasuda K; Yamamoto M; Akira S; Nakanishi K; Noda T; Taniguchi S
    Genes Cells; 2004 Nov; 9(11):1055-67. PubMed ID: 15507117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
    Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
    Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
    Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
    Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes.
    Hawn TR; Ozinsky A; Williams LM; Rodrigues S; Clark A; Pham U; Hill HR; Ochs H; Aderem A; Liles WC
    Hum Immunol; 2005 Jul; 66(7):842-7. PubMed ID: 16112032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.
    Kawai T; Sato S; Ishii KJ; Coban C; Hemmi H; Yamamoto M; Terai K; Matsuda M; Inoue J; Uematsu S; Takeuchi O; Akira S
    Nat Immunol; 2004 Oct; 5(10):1061-8. PubMed ID: 15361868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
    O'Neill LA; Bowie AG
    Nat Rev Immunol; 2007 May; 7(5):353-64. PubMed ID: 17457343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.